IN2013MU03773A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03773A
IN2013MU03773A IN3773MU2013A IN2013MU03773A IN 2013MU03773 A IN2013MU03773 A IN 2013MU03773A IN 3773MU2013 A IN3773MU2013 A IN 3773MU2013A IN 2013MU03773 A IN2013MU03773 A IN 2013MU03773A
Authority
IN
India
Prior art keywords
hyaluronic acid
crosslinked hyaluronic
preparation
composition
same
Prior art date
Application number
Inventor
Joon Ho Lee
Chung Lee
Han Seung Lee
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of IN2013MU03773A publication Critical patent/IN2013MU03773A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention relates to a composition for preparation of viscoelastic crosslinked hyaluronic acid, and crosslinked hyaluronic acid obtained by using the same, and more specifically to a composition for preparation of viscoelastic crosslinked hyaluronic acid, comprising hyaluronic acid alkaline aqueous solution of 15 to 25 weight % concentration and a crosslinking agent, and having Tan 6 value of 0.5 to 1.5 at the frequency of 0.02 to 1 Hz, and crosslinked hyaluronic acid obtained by using the same.
IN3773MU2013 2013-03-27 2013-12-02 IN2013MU03773A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130032956A KR101869988B1 (en) 2013-03-27 2013-03-27 A composition for preparation of viscoelastic crosslinked hyaluronic acid, and crosslinked hyaluronic acid obtained by using the same

Publications (1)

Publication Number Publication Date
IN2013MU03773A true IN2013MU03773A (en) 2015-08-07

Family

ID=51594442

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3773MU2013 IN2013MU03773A (en) 2013-03-27 2013-12-02

Country Status (10)

Country Link
KR (1) KR101869988B1 (en)
CN (2) CN104072814A (en)
AR (1) AR093689A1 (en)
BR (1) BR102013030668B1 (en)
IN (1) IN2013MU03773A (en)
MX (1) MX366526B (en)
MY (1) MY169325A (en)
RU (1) RU2568998C2 (en)
TR (1) TR201313318A2 (en)
TW (1) TWI522134B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160268291A1 (en) * 2015-03-13 2016-09-15 Kabushiki Kaisha Toshiba Semiconductor device and manufacturing method of semiconductor device
KR101720426B1 (en) * 2015-09-01 2017-04-14 (주)시지바이오 Composition comprising hyaluronic acid and the method for preparing the same
CN112423798B (en) * 2018-07-06 2022-07-19 株式会社Lg化学 Hyaluronic acid filler with high viscoelasticity and high cohesiveness
EP3804770B1 (en) * 2018-07-10 2023-12-06 Lg Chem, Ltd. Hyaluronic acid filler having high lift capacity and low injection force
KR102395184B1 (en) * 2020-03-10 2022-05-10 (주)메디톡스 Crosslinked hyaluronic acid which is neither monophasic nor biphasic, and use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
HU224697B1 (en) * 1995-11-15 2006-01-30 Seikagaku Kogyo Co Ltd Photocured cross-linked-hyaluronic acid gel and method of preparation thereof
FR2811996B1 (en) * 2000-07-19 2003-08-08 Corneal Ind CROSS-LINKING OF POLYSACCHARIDE (S), PREPARATION OF HYDROGEL (S); POLYSACCHARIDE (S) AND HYDROGEL (S) OBTAINED, THEIR USES
SE0401182D0 (en) * 2004-05-05 2004-05-05 Q Med Ab Novel use of a viscoelastic composition
WO2006051950A1 (en) * 2004-11-15 2006-05-18 Shiseido Co., Ltd. Method for producing crosslinked hyaluronic acid gel
KR100852944B1 (en) * 2007-02-15 2008-08-19 (주)아모레퍼시픽 Preparation method of chemically cross-linked hyaluronic acid hydrogel nanoparticles
CN101244290A (en) * 2007-11-30 2008-08-20 顾其胜 Method for preparing crosslinked hyaluronic acid microgel for tissue filling
CN101538377A (en) * 2008-03-20 2009-09-23 上海昊海生物科技有限公司 Cross-linked hyaluronic acid gel and preparation method thereof
CN101759881A (en) * 2008-10-08 2010-06-30 上海建华精细生物制品有限公司 Medical cross-linking sodium hyaluronate gel derivative product and preparation method thereof
CN101724164B (en) * 2008-10-31 2011-12-14 科妍生物科技股份有限公司 Method for preparing cross-linked hyaluronic acid
CN102188712A (en) * 2010-03-04 2011-09-21 上海其胜生物制剂有限公司 Method for preparing injectable microgelparticles
CN102120833A (en) * 2011-01-10 2011-07-13 深圳市资福药业有限公司 Hyaluronate gel particle and preparation method thereof
CN102952275A (en) * 2011-08-19 2013-03-06 上海建华精细生物制品有限公司 Hyaluronic acid gel employing biphasic technology, and preparation method thereof

Also Published As

Publication number Publication date
TW201436827A (en) 2014-10-01
TR201313318A2 (en) 2014-10-21
AR093689A1 (en) 2015-06-17
KR101869988B1 (en) 2018-06-21
MX2013013828A (en) 2014-09-26
KR20140117956A (en) 2014-10-08
TWI522134B (en) 2016-02-21
BR102013030668A8 (en) 2018-05-08
MY169325A (en) 2019-03-21
RU2568998C2 (en) 2015-11-20
BR102013030668A2 (en) 2015-08-04
RU2013153007A (en) 2015-06-10
CN104072814A (en) 2014-10-01
MX366526B (en) 2019-07-11
BR102013030668B1 (en) 2020-04-07
CN110078978A (en) 2019-08-02

Similar Documents

Publication Publication Date Title
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
AU2015207757A8 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201692526A1 (en) SUBSTITUTED [1,2,4] TRIAZOLE COMPOUNDS
EA201590887A1 (en) COMPOSITION
EA201692525A1 (en) SUBSTITUTED COMPOUNDS [1,2,4] TRIAOSOL AND IMIDAZOL AS FUNGICIDES
WO2014086982A3 (en) Stable metal compounds, their compositions and methods of their use
MX2016005760A (en) Gsk-3 inhibitors.
PH12015502118A1 (en) Pyridin-4-yl derivatives
CR20200275A (en) Hydroxyisoxazolines and derivatives thereof
MX349265B (en) Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof.
MX2014005510A (en) Novel compositions, preparation thereof and use thereof for production of cast polyamides.
MX2020002123A (en) Ribociclib salts and solid state forms thereof.
IN2013MU03773A (en)
MX362562B (en) Soluble aqueous compositions of selected polyitaconic acid polymers.
UA113540C2 (en) N- (2-METHOXYBENZOYL) POLYMORPHS -4 - $ (METHYLAMINOCARBONYL) AMINO] BENZOLSULPHONAMIDE
IN2014CH00304A (en)
MX2015012211A (en) Ionic liquids and uses thereof.
EA201690797A1 (en) NEW CONNECTIONS
MX367773B (en) Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof.
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
MX2017001900A (en) Nasal composition comprising mixture of hyaluronic acids and saline solution.
EA201492173A1 (en) DRONEDARON FOR APPLICATION IN LEUSHMANIOSIS, IN COMPOSITIONS AND COMBINATIONS FOR APPLICATION IN LEISHMANIOSIS
UA84257U (en) USE OF SODIUM SALT OF 4-(2-OXO-3-METHYL-2H-[1,2,4]TRIAZINO[2,3-c]-QUINASOLIN-6-YL) BUTANOIC ACID AS CEREBROPROTECTIVE AGENT
UA79866U (en) use of derivatives of 2-oxoindoline-3-glyoxalic acid as agents with antidepressive action